Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan
2023-06-21 09:00
Growing Awareness of Brain Health for Senior Dogs as Cascade Animal Sciences Launches "Neuro-Pro"
2023-06-20 22:17
Clarity commences COMBAT theranostic prostate cancer trial in the US
2023-06-20 21:03
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023
2023-06-20 21:00
Minghui Pharmaceutical Inc. Announces First Patient Dosing in Phase 1 Clinical Studies of Both the Antibody-Drug Conjugate Programs Targeting TROP-2 or B7-H3 Respectively, for Treatment of Advanced or Metastatic Solid Tumors
2023-06-20 18:30
Together for Health - Parenting the Future: Symposium on Fertility Support and Childcare Development in Rural Areas Held in Xi'an, China
2023-06-20 11:53
Curocell announced encouraging updates on the next-generation anti-CD19 CAR-T, Anbalcabtagene-autoleucel at International Conference on Malignant Lymphoma (ICML) 2023
2023-06-20 08:01
Bergen Prepares to Host International Conference on Hansen's Disease Marking 150 Years Since the Discovery of the Leprosy Bacillus
2023-06-19 19:00
The Summit Forum on the Application and Construction of AGP in China Takes Place in Shenzhen
2023-06-19 16:00
The exchanges between China and Austria on TCM have yielded fruitful results
2023-06-19 13:28
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE
2023-06-17 07:04
China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
2023-06-17 04:29
The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer
2023-06-16 22:01
SeekIn paves the way for cancer early detection in low- and middle-income countries
2023-06-16 21:00
Cholesgen to enter into a drug discovery collaboration and licensing option agreement in hypercholesterolemia with AstraZeneca
2023-06-16 18:00
Singleron launches two new instruments to further standardize single cell analysis workflow
2023-06-16 16:18
DeerRun Launches Women's Exclusive Smart Under-Desk Treadmill
2023-06-16 08:30
BrightMD Fair China 2023 Concludes Successfully, Fostering Collaborative Synergies in Shenzhen
2023-06-15 21:02
Vatech's EzRay Air Series Continues to achieve Record-Breaking Sales Performance Worldwide
2023-06-15 21:00
Mabwell Announces the U.S. FDA approval of 9MW3811 for IND
2023-06-15 21:00
1
53
54
55
56
57
764